Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for ...

Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Retail chatter surged for Abbott and Dexcom on Tuesday after U.S. Health Secretary Robert F. Kennedy Jr. announced a sweeping ...

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for ...

The Diabetes Devices Market was valued at US$ 33.4 Billion in 2024 and is projected to reach US$ 64.8 Billion by 2033, growing at a CAGR of 7.7%. The U.S. diabetes devices market is witnessing strong ...

DexCom DXCM delivered robust first-quarter 2025 results, underpinned by strong category demand, record new patient growth and ...

FN Media Group News Commentary - The global diabetic retinopathy market has shown a consistent growth in recent years and is expected to continue for the coming several years. According to a ...

On May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business into a ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, margins, and shareholder returns.

Medtronic plc, a global leader in healthcare technology, announced the US Food and Drug Administration (FDA) approval for the Simplera Sync sensor for use with the MiniMed 780G system. With this ...

US FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system Galway, Ireland Monday, April 21, 2025, 11:00 Hrs [IST] Medtronic plc, a global leader in healthcare technology, ...